Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CVM
CVM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CVM News
Cel-Sci CEO Buys Shares, Stock Rises 7%
Jan 26 2026
stocktwits
CEL-SCI Files for Breakthrough Designation for Multikine in Saudi Arabia, Plans 212-Patient Enrollment in 2026
Dec 29 2025
Newsfilter
Emerging Growth Stocks Experience Significant Gains in After-Hours Trading
Sep 19 2025
NASDAQ.COM
Stock Market Update: Nvidia Weighs on Nasdaq Futures—Attention on Dollar General, Dell, and Best Buy
Aug 28 2025
Benzinga
Snowflake Shares Surge 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 28 2025
Benzinga
What’s Causing the After-Hours Plunge in CEL-SCI Stock?
Aug 28 2025
Benzinga
CEL-SCI Corp. Sets Public Offering Price at $9.00 per Share for 1.11 Million Shares
Aug 28 2025
NASDAQ.COM
CEL-SCI reveals pricing details for $10 million public offering
Aug 28 2025
SeekingAlpha
CEL-SCI Unveils Plans for Public Offering
Aug 27 2025
Newsfilter
CEL-SCI Stock Declines Following Announcement of Public Offering
Aug 27 2025
SeekingAlpha
CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results
Aug 14 2025
Newsfilter
CEL-SCI's Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
Aug 13 2025
Newsfilter
Monday 7/28 Insider Buying Report: CVM, LOOP
Jul 28 2025
NASDAQ.COM
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Jul 14 2025
Benzinga
Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Jul 14 2025
Benzinga
CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules
Jul 11 2025
Newsfilter
Show More News
